{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T08:41:59Z","timestamp":1779352919969,"version":"3.51.4"},"reference-count":62,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T00:00:00Z","timestamp":1618272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Endogenous mechanisms underlying bacterial infection resolution are essential for the development of novel therapies for the treatment of inflammation caused by infection without unwanted side effects. Herein, we found that erythropoietin (EPO) promoted the resolution and enhanced antibiotic actions in <jats:italic>Escherichia coli<\/jats:italic> (<jats:italic>E. coli<\/jats:italic>)- and <jats:italic>Staphylococcus aureus<\/jats:italic> (<jats:italic>S. aureus<\/jats:italic>)-initiated infections. Levels of peritoneal EPO and macrophage erythropoietin receptor (EPOR) were elevated in self-limited <jats:italic>E. coli-<\/jats:italic>initiated peritonitis. Myeloid-specific EPOR-deficient mice exhibited an impaired inflammatory resolution and exogenous EPO enhanced this resolution in self-limited infections. Mechanistically, EPO increased macrophage clearance of bacteria <jats:italic>via<\/jats:italic> peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3)-induced CD36. Moreover, EPO ameliorated inflammation and increased the actions of ciprofloxacin and vancomycin in resolution-delayed <jats:italic>E. coli<\/jats:italic>- and <jats:italic>S. aureus<\/jats:italic>-initiated infections. Collectively, macrophage EPO signaling is temporally induced during infections. EPO is anti-phlogistic, increases engulfment, promotes infection resolution, and lowers antibiotic requirements.<\/jats:p>","DOI":"10.3389\/fimmu.2021.658715","type":"journal-article","created":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T05:08:45Z","timestamp":1618290525000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Erythropoietin Promotes Infection Resolution and Lowers Antibiotic Requirements in E. coli- and S. aureus-Initiated Infections"],"prefix":"10.3389","volume":"12","author":[{"given":"Feihong","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiting","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Mei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengxue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bangwei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiren","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.chom.2019.06.004","article-title":"Non-traditional Antibacterial Therapeutic Options and Challenges","volume":"26","author":"Theuretzbacher","year":"2019","journal-title":"Cell Host Microbe"},{"key":"B2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nrd.2017.162","article-title":"Host-directed therapies for bacterial and viral infections","volume":"17","author":"Kaufmann","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)00078-5","article-title":"Host-directed therapies for infectious diseases: current status, recent progress, and future prospects","volume":"16","author":"Zumla","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro2745","article-title":"Modulating immunity as a therapy for bacterial infections","volume":"10","author":"Hancock","year":"2012","journal-title":"Nat Rev Microbiol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/nri2779","article-title":"Phagocyte partnership during the onset and resolution of inflammation","volume":"10","author":"Soehnlein","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nri.2015.4","article-title":"Specialized pro-resolving mediators: endogenous regulators of infection and inflammation","volume":"16","author":"Basil","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nature13479","article-title":"Pro-resolving lipid mediators are leads for resolution physiology","volume":"510","author":"Serhan","year":"2014","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12871","article-title":"Novel mediators and mechanisms in the resolution of infectious inflammation: evidence for vagus regulation","volume":"286","author":"Serhan","year":"2019","journal-title":"J Internal Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201601222R","article-title":"Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms","volume":"31","author":"Serhan","year":"2017","journal-title":"FASEB J"},{"key":"B10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.mam.2017.03.007","article-title":"Does promoting resolution instead of inhibiting inflammation represent the new paradigm in treating infections","volume":"58","author":"Dalli","year":"2017","journal-title":"Mol Aspects Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.60.050307.110718","article-title":"Erythropoietin in cancer patients","volume":"60","author":"Glaspy","year":"2009","journal-title":"Annu Rev Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"12177","DOI":"10.1038\/ncomms12177","article-title":"Phagocyte respiratory burst activates macrophage erythropoietin signalling to promote acute inflammation resolution","volume":"7","author":"Luo","year":"2016","journal-title":"Nat Commun"},{"key":"B13","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.immuni.2016.01.002","article-title":"Erythropoeitin Signaling in Macrophages Promotes Dying Cell Clearance and Immune Tolerance","volume":"44","author":"Luo","year":"2016","journal-title":"Immunity"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2011.06.045","article-title":"Erythropoietin, erythropoiesis and beyond","volume":"82","author":"Chateauvieux","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2013.04.015","article-title":"Erythropoietin is a hypoxia inducible factor-induced protective molecule in experimental autoimmune neuritis","volume":"1832","author":"Luo","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/nrn1687","article-title":"Emerging biological roles for erythropoietin in the nervous system","volume":"6","author":"Brines","year":"2005","journal-title":"Nat Rev Neurosci"},{"key":"B17","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.pneurobio.2008.02.002","article-title":"Erythropoietin: elucidating new cellular targets that broaden therapeutic strategies","volume":"85","author":"Maiese","year":"2008","journal-title":"Prog Neurobiol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2011.10.005","article-title":"The pleiotropic effects of erythropoietin in infection and inflammation","volume":"14","author":"Nairz","year":"2012","journal-title":"Microbes Infect"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.2174\/138161211796197115","article-title":"The potential role of erythropoietin as a pleiotropic agent in post-cardiac arrest syndrome","volume":"17","author":"Xanthos","year":"2011","journal-title":"Curr Pharm Des"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2018.10.005","article-title":"The deficiency of macrophage erythropoietin signaling contributes to delayed acute inflammation resolution in diet-induced obese mice","volume":"1865","author":"Luo","year":"2019","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3201\/eid0505.990502","article-title":"Food-related illness and death in the United States","volume":"5","author":"Mead","year":"1999","journal-title":"Emerg Infect Dis"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/nature11042","article-title":"Infection regulates pro-resolving mediators that lower antibiotic requirements","volume":"484","author":"Chiang","year":"2012","journal-title":"Nature"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/nature05877","article-title":"Resolvin E1 and protectin D1 activate inflammation-resolution programmes","volume":"447","author":"Schwab","year":"2007","journal-title":"Nature"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/ni1276","article-title":"Resolution of inflammation: the beginning programs the end","volume":"6","author":"Serhan","year":"2005","journal-title":"Nat Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2007.06.010","article-title":"PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties","volume":"6","author":"Bouhlel","year":"2007","journal-title":"Cell Metab"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e1597","DOI":"10.1038\/cddis.2014.544","article-title":"Macrophage peroxisome proliferator-activated receptor gamma deficiency delays skin wound healing through impairing apoptotic cell clearance in mice","volume":"6","author":"Chen","year":"2015","journal-title":"Cell Death Dis"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-physiol-021909-135846","article-title":"Macrophages, inflammation, and insulin resistance","volume":"72","author":"Olefsky","year":"2010","journal-title":"Annu Rev Physiol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"549691","DOI":"10.1155\/2015\/549691","article-title":"PPARgamma and the Innate Immune System Mediate the Resolution of Inflammation","volume":"2015","author":"Croasdell","year":"2015","journal-title":"PPAR Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1002230","article-title":"Autoimmune kidney disease and impaired engulfment of apoptotic cells in mice with macrophage peroxisome proliferator-activated receptor gamma or retinoid X receptor alpha deficiency","volume":"186","author":"Roszer","year":"2011","journal-title":"J Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"640769","DOI":"10.1155\/2012\/640769","article-title":"Peroxisome Proliferator-Activator Receptor gamma: A Link between Macrophage CD36 and Inflammation in Malaria Infection","volume":"2012","author":"Ren","year":"2012","journal-title":"PPAR Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200501113","article-title":"Response to Staphylococcus aureus requires CD36-mediated phagocytosis triggered by the COOH-terminal cytoplasmic domain","volume":"170","author":"Stuart","year":"2005","journal-title":"J Cell Biol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s15010-017-1100-6","article-title":"Evaluation and management of Staphylococcus aureus bacteriuria: an updated review","volume":"46","author":"Karakonstantis","year":"2018","journal-title":"Infection"},{"key":"B33","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1146\/annurev-biochem-060614-034516","article-title":"Mechanisms of Methicillin Resistance in Staphylococcus aureus","volume":"84","author":"Peacock","year":"2015","journal-title":"Annu Rev Biochem"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01121","article-title":"Anti-Methicillin-Resistant Staphylococcus aureus Nanoantibiotics","volume":"10","author":"Labruere","year":"2019","journal-title":"Front Pharmacol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.02.009","article-title":"Proresolving lipid mediators and mechanisms in the resolution of acute inflammation","volume":"40","author":"Buckley","year":"2014","journal-title":"Immunity"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-physiol-021113-170408","article-title":"Resolution of acute inflammation in the lung","volume":"76","author":"Levy","year":"2014","journal-title":"Annu Rev Physiol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"a016311","DOI":"10.1101\/cshperspect.a016311","article-title":"Lipid mediators in the resolution of inflammation","volume":"7","author":"Serhan","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s004010000297","article-title":"Erythropoietin and erythropoietin receptor in human ischemic\/hypoxic brain","volume":"101","author":"Siren","year":"2001","journal-title":"Acta Neuropathol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2004.06.057","article-title":"Hypoxia-ischemia affects erythropoietin and erythropoietin receptor expression pattern in the neonatal rat brain","volume":"1021","author":"Spandou","year":"2004","journal-title":"Brain Res"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2007.0358","article-title":"Differential neuroprotective properties of endogenous and exogenous erythropoietin in a mouse model of traumatic brain injury","volume":"25","author":"Shein","year":"2008","journal-title":"J Neurotrauma"},{"key":"B41","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/1475-2875-8-261","article-title":"Erythropoietin and its receptors in the brainstem of adults with fatal falciparum malaria","volume":"8","author":"Medana","year":"2009","journal-title":"Malaria J"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.2119\/2008-00086.Mengozzi","article-title":"Endogenous erythropoietin as part of the cytokine network in the pathogenesis of experimental autoimmune encephalomyelitis","volume":"14","author":"Mengozzi","year":"2008","journal-title":"Mol Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20285","article-title":"A novel endogenous erythropoietin mediated pathway prevents axonal degeneration","volume":"56","author":"Keswani","year":"2004","journal-title":"Ann Neurol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/ncomms1526","article-title":"Disrupted erythropoietin signalling promotes obesity and alters hypothalamus proopiomelanocortin production","volume":"2","author":"Teng","year":"2011","journal-title":"Nat Commun"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.2337\/dc07-2075","article-title":"Expression of erythropoietin and its receptor in the human retina: a comparative study of diabetic and nondiabetic subjects","volume":"31","author":"Garcia-Ramirez","year":"2008","journal-title":"Diabetes Care"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S28186","article-title":"Skin regeneration with conical and hair follicle structure of deep second-degree scalding injuries via combined expression of the EPO receptor and beta common receptor by local subcutaneous injection of nanosized rhEPO","volume":"7","author":"Bader","year":"2012","journal-title":"Int J Nanomedicine"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardiores.2006.05.010","article-title":"Endogenous erythropoietin system in non-hematopoietic lineage cells plays a protective role in myocardial ischemia\/reperfusion","volume":"71","author":"Tada","year":"2006","journal-title":"Cardiovasc Res"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20100665","article-title":"Erythropoietin protects against diabetes through direct effects on pancreatic beta cells","volume":"207","author":"Choi","year":"2010","journal-title":"J Exp Med"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20122760","article-title":"Erythropoietin: multiple targets, actions, and modifying influences for biological and clinical consideration","volume":"210","author":"Broxmeyer","year":"2013","journal-title":"J Exp Med"},{"key":"B50","doi-asserted-by":"publisher","first-page":"a011619","DOI":"10.1101\/cshperspect.a011619","article-title":"Erythropoietin","volume":"3","author":"Bunn","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.154625","article-title":"Erythropoietin protects intestinal epithelial barrier function and lowers the incidence of experimental neonatal necrotizing enterocolitis","volume":"286","author":"Shiou","year":"2011","journal-title":"J Biol Chem"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9568.2003.02875.x","article-title":"Exogenous erythropoietin protects against dorsal root ganglion apoptosis and pain following peripheral nerve injury","volume":"18","author":"Campana","year":"2003","journal-title":"Eur J Neurosci"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00164-16","article-title":"Enhanced Clearance of Pseudomonas aeruginosa by Peroxisome Proliferator-Activated Receptor Gamma","volume":"84","author":"Bedi","year":"2016","journal-title":"Infect Immun"},{"key":"B54","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.chom.2018.07.001","article-title":"Peroxisome Proliferator-Activated Receptor gamma Is Essential for the Resolution of Staphylococcus aureus Skin Infections","volume":"24","author":"Thurlow","year":"2018","journal-title":"Cell Host Microbe"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.7.5004","article-title":"The synthetic peroxisome proliferator-activated receptor-gamma agonist ciglitazone attenuates neuroinflammation and accelerates encapsulation in bacterial brain abscesses","volume":"180","author":"Kielian","year":"2008","journal-title":"J Immunol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.immuni.2011.01.002","article-title":"Erythropoietin contrastingly affects bacterial infection and experimental colitis by inhibiting nuclear factor-kappaB-inducible immune pathways","volume":"34","author":"Nairz","year":"2011","journal-title":"Immunity"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro2128","article-title":"Antimicrobial mechanisms of phagocytes and bacterial evasion strategies","volume":"7","author":"Flannagan","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.02.014","article-title":"Molecular Determinants in Phagocyte-Bacteria Interactions","volume":"44","author":"Kaufmann","year":"2016","journal-title":"Immunity"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2013.07.009","article-title":"PPARgamma-mediated increase in glucose availability sustains chronic Brucella abortus infection in alternatively activated macrophages","volume":"14","author":"Xavier","year":"2013","journal-title":"Cell Host Microbe"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2013.07.010","article-title":"Salmonella require the fatty acid regulator PPARdelta for the establishment of a metabolic environment essential for long-term persistence","volume":"14","author":"Eisele","year":"2013","journal-title":"Cell Host Microbe"},{"key":"B61","doi-asserted-by":"publisher","first-page":"383829","DOI":"10.1155\/2012\/383829","article-title":"PPARgamma Expression and Function in Mycobacterial Infection: Roles in Lipid Metabolism, Immunity, and Bacterial Killing","volume":"2012","author":"Almeida","year":"2012","journal-title":"PPAR Res"},{"key":"B62","doi-asserted-by":"publisher","first-page":"e37349","DOI":"10.1371\/journal.pone.0037349","article-title":"Lack of PPARgamma in myeloid cells confers resistance to Listeria monocytogenes infection","volume":"7","author":"Abdullah","year":"2012","journal-title":"PloS One"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.658715\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T05:08:47Z","timestamp":1618290527000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.658715\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,13]]},"references-count":62,"alternative-id":["10.3389\/fimmu.2021.658715"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.658715","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,13]]},"article-number":"658715"}}